1. Home
  2. AXTI vs IVVD Comparison

AXTI vs IVVD Comparison

Compare AXTI & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • IVVD
  • Stock Information
  • Founded
  • AXTI 1986
  • IVVD 2020
  • Country
  • AXTI United States
  • IVVD United States
  • Employees
  • AXTI N/A
  • IVVD N/A
  • Industry
  • AXTI Semiconductors
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • IVVD Health Care
  • Exchange
  • AXTI Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • AXTI 84.8M
  • IVVD 69.0M
  • IPO Year
  • AXTI 1998
  • IVVD 2021
  • Fundamental
  • Price
  • AXTI $2.36
  • IVVD $0.68
  • Analyst Decision
  • AXTI Strong Buy
  • IVVD Strong Buy
  • Analyst Count
  • AXTI 4
  • IVVD 3
  • Target Price
  • AXTI $4.64
  • IVVD $5.85
  • AVG Volume (30 Days)
  • AXTI 455.8K
  • IVVD 1.2M
  • Earning Date
  • AXTI 07-31-2025
  • IVVD 08-13-2025
  • Dividend Yield
  • AXTI N/A
  • IVVD N/A
  • EPS Growth
  • AXTI N/A
  • IVVD N/A
  • EPS
  • AXTI N/A
  • IVVD N/A
  • Revenue
  • AXTI $96,029,000.00
  • IVVD $36,688,000.00
  • Revenue This Year
  • AXTI N/A
  • IVVD $446.60
  • Revenue Next Year
  • AXTI $28.89
  • IVVD $112.63
  • P/E Ratio
  • AXTI N/A
  • IVVD N/A
  • Revenue Growth
  • AXTI 21.44
  • IVVD N/A
  • 52 Week Low
  • AXTI $1.13
  • IVVD $0.35
  • 52 Week High
  • AXTI $4.03
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 60.82
  • IVVD 40.96
  • Support Level
  • AXTI $2.10
  • IVVD $0.70
  • Resistance Level
  • AXTI $2.62
  • IVVD $0.76
  • Average True Range (ATR)
  • AXTI 0.17
  • IVVD 0.05
  • MACD
  • AXTI 0.00
  • IVVD -0.00
  • Stochastic Oscillator
  • AXTI 60.61
  • IVVD 5.11

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: